Objective 4 - Outcomes
================
Last Updated: November 01 2018

<p>
This folder will contain all information regarding the analyses performed for objective 4
</p>
<p>
<b>Objective 4</b>: To examine and compare the rates of major adverse outcomes for warfarin, apixaban, rivaroxaban and dabigatran, and to determine if the outcomes vary by sex, age, socioeconomic status for the different anticoagulants.
</p>
<h3>
Objective Progress Table
</h3>
<table style="width:100%">
<tr>
    <th>Task</th>
    <th>Status</th>
    <th>Date Completed</th>
    <th>Filename</th>

</tr>
<tr>
    <td>Define Cohort</td>
    <td></td>
    <td></td>
    <td></td>

</tr>
<tr>
    <td>Create Research Dataset</td>
    <td></td>
    <td></td>
    <td></td>

</tr>
    <tr>
    <td>Analyses</td>
    <td></td>
    <td></td>
    <td></td>

</tr>
    <tr>
    <td>Figures</td>
    <td></td>
    <td></td>
    <td></td>

</tr>
    <tr>
    <td>Tables</td>
    <td></td>
    <td></td>
    <td></td>

</tr>
<tr>
    <td>Summary Report</td>
    <td></td>
    <td></td>
    <td></td>

</tr>
</table>
